Skip to main content
. 2018 Sep 20;118(10):1743–1751. doi: 10.1055/s-0038-1668545

Fig. 1.

Fig. 1

Patients' recruitment. *Five autoimmune thrombotic thrombocytopenic purpura (iTTP) patients consulted the UMC after having survived their first acute episode. At the time of consultation they showed a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13 (ADAMTS13) activities of 16, 19, 15, 17 and 18%, with/ without weak ADAMTS13 inhibitors. All other iTTP patients had documented severe ADAMTS13 deficiency (< 10%) during acute episode.